会員登録
ログイン
【4597】ソレイジア・ファーマ
創薬。がんに注力。大株主に伊藤忠商事。
類似企業：
【業界1位】
武田薬品工業
【業界1位】
武田薬品工業
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
| 決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025.12 | 2025/02/12 | 当初予 | 1,300 | - | -650 | - | -650 | - | -650 | - |
| 2024.12 | 2025/02/12 | 実 | 316 | ↑ | -1,951 | ↓ | -1,961 | ↓ | -1,941 | ↓ |
| 2024.12 | 2025/01/06 | 修正予 | 300 | ↑ | -1,050 | ↑ | -1,050 | ↑ | -1,050 | ↑ |
| 2024.12 | 2024/12/27 | 修正予 | 160 | ↓ | -1,150 | ↓ | -1,150 | ↓ | -1,150 | ↓ |
| 2024.12 | 2024/11/13 | Q3予 | 1,375 | → | -675 | → | -675 | → | -675 | → |
| 2024.12 | 2024/08/14 | Q2予 | 1,375 | → | -675 | → | -675 | → | -675 | → |
| 2024.12 | 2024/05/15 | Q1予 | 1,375 | → | -675 | ↓ | -675 | → | -675 | → |
| 2024.12 | 2024/02/14 | 当初予 | 1,375 | - | -650 | - | -675 | - | -675 | - |
| 2023.12 | 2024/02/14 | 実 | 617 | ↓ | -1,139 | ↑ | -1,135 | ↑ | -1,112 | ↑ |
| 2023.12 | 2023/12/28 | 修正予 | 620 | ↓ | -1,150 | ↓ | -1,150 | ↓ | -1,150 | ↓ |
| 2023.12 | 2023/11/13 | Q3予 | 1,400 | → | -750 | → | -750 | → | -750 | → |
| 2023.12 | 2023/08/10 | Q2予 | 1,400 | → | -750 | → | -750 | → | -750 | → |
| 2023.12 | 2023/05/15 | Q1予 | 1,400 | → | -750 | → | -750 | → | -750 | → |
| 2023.12 | 2023/02/14 | 当初予 | 1,400 | - | -750 | - | -750 | - | -750 | - |
| 2022.12 | 2023/02/14 | 実 | 1,092 | ↓ | -2,470 | ↓ | -2,492 | ↓ | -2,548 | ↓ |
| 2022.12 | 2022/11/25 | 修正予 | 1,150 | → | -2,350 | ↓ | -2,375 | ↓ | -2,450 | ↓ |
| 2022.12 | 2022/11/14 | Q3予 | 1,150 | ↓ | -2,150 | ↓ | -2,175 | ↓ | -2,250 | ↓ |
| 2022.12 | 2022/08/15 | Q2予 | 3,050 | → | -475 | → | -475 | → | -575 | → |
| 2022.12 | 2022/05/13 | Q1予 | 3,050 | → | -475 | → | -475 | → | -575 | → |
| 2022.12 | 2022/02/09 | 当初予 | 3,050 | - | -475 | - | -475 | - | -575 | - |
| 2021.12 | 2022/02/09 | 実 | 559 | ↓ | -2,419 | ↑ | -2,442 | ↑ | -2,478 | ↑ |
| 2021.12 | 2021/11/10 | Q3予 | 600 | ↓ | -2,500 | ↓ | -2,500 | ↓ | -2,500 | ↓ |
| 2021.12 | 2021/08/11 | Q2予 | 2,100 | → | -2,300 | → | -2,300 | → | -2,300 | → |
| 2021.12 | 2021/05/12 | Q1予 | 2,100 | → | -2,300 | → | -2,300 | → | -2,300 | → |
| 2021.12 | 2021/02/10 | 当初予 | 2,100 | - | -2,300 | - | -2,300 | - | -2,300 | - |
| 2020.12 | 2021/02/10 | 実 | 454 | ↑ | -4,116 | ↑ | -4,159 | ↑ | -4,127 | ↑ |
| 2020.12 | 2020/12/15 | 修正予 | 450 | ↓ | -4,200 | ↓ | -4,200 | ↓ | -4,200 | ↓ |
| 2020.12 | 2020/11/13 | Q3予 | 1,250 | → | -2,450 | → | -2,450 | → | -2,450 | → |
| 2020.12 | 2020/08/12 | Q2予 | 1,250 | → | -2,450 | → | -2,450 | → | -2,450 | → |
| 2020.12 | 2020/05/14 | Q1予 | 1,250 | → | -2,450 | → | -2,450 | → | -2,450 | → |
| 2020.12 | 2020/02/13 | 当初予 | 1,250 | - | -2,450 | - | -2,450 | - | -2,450 | - |
| 2019.12 | 2020/02/13 | 実 | 1,310 | ↑ | -1,762 | ↑ | -1,797 | ↑ | -1,867 | ↑ |
| 2019.12 | 2019/11/13 | Q3予 | 1,100 | → | -2,500 | → | -2,500 | → | -2,500 | → |
| 2019.12 | 2019/08/14 | Q2予 | 1,100 | → | -2,500 | → | -2,500 | → | -2,500 | → |
| 2019.12 | 2019/05/15 | Q1予 | 1,100 | → | -2,500 | → | -2,500 | → | -2,500 | → |
| 2019.12 | 2019/02/13 | 当初予 | 1,100 | - | -2,500 | - | -2,500 | - | -2,500 | - |
| 2018.12 | 2019/02/13 | 実 | 318 | ↓ | -2,420 | ↑ | -2,445 | ↑ | -2,422 | ↑ |
| 2018.12 | 2018/11/14 | Q3予 | 350 | → | -3,100 | → | -3,100 | → | -3,100 | → |
| 2018.12 | 2018/08/10 | Q2予 | 350 | → | -3,100 | → | -3,100 | → | -3,100 | → |
| 2018.12 | 2018/05/15 | Q1予 | 350 | → | -3,100 | → | -3,100 | → | -3,100 | → |
| 2018.12 | 2018/02/09 | 当初予 | 350 | - | -3,100 | - | -3,100 | - | -3,100 | - |
| 2017.12 | 2018/02/09 | 実 | 410 | → | -1,009 | ↑ | -1,016 | ↑ | -1,007 | ↑ |
| 2017.12 | 2017/12/22 | 修正予 | 410 | ↓ | -1,100 | ↑ | -1,100 | ↑ | -1,100 | ↑ |
| 2017.12 | 2017/11/14 | Q3予 | 423 | → | -1,787 | → | -1,793 | → | -1,798 | → |
| 2017.12 | 2017/08/10 | Q2予 | 423 | → | -1,787 | → | -1,793 | → | -1,798 | → |
| 2017.12 | 2017/05/15 | 当初予 | 423 | - | -1,787 | - | -1,793 | - | -1,798 | - |
